US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 28 - BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- III

US FDA/CFSAN - BSE and Cosmetics: FDA Risk Assessment and Management Perspectives December 7, 2006

US FDA/CFSAN

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives

December 7, 2006

BSE/ v-CJD: OCAC Role In Process of BSE Risk Analysis- III

2001-2003: OCAC Support to FDA Field
- Bovine Stem Cell Imports for 'Cosmetic' Use
  - LOS-DO, CBER
2001-2004: OCAC International Outreach
- Health Canada Risk Assessment (Focal Point Research)
- Guidance on BSE Risk Management
  - KFDA (Korea)
  - MHLW (Japan)

Slide 28 of 45

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45

Slide 28 of 45